Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.
Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page.SummaryDifference0.2%
- Check8 days agoChange DetectedNew site revision label v3.3.4 was added and v3.3.3 was removed, with no changes to the study details or other content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedMelanoma and related topics: MedlinePlus Genetics were added as related topics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check30 days agoChange DetectedIntroduced a new Locations section that lists Iowa, Minnesota, New Mexico, and Utah as study sites. Corresponding location entries for these states were removed from the previous content.SummaryDifference0.7%
- Check38 days agoChange DetectedMelanoma is added to the related topics section under MedlinePlus Genetics on the Study Details page.SummaryDifference0.2%
- Check52 days agoChange DetectedMelanoma and the related topic MedlinePlus Genetics were removed from the Related Topics/MeSH section. This change is a minor metadata adjustment that does not alter the study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.